Comprehensive analysis identifies ARHGEF6 as a potential prognostic and immunological biomarker in lung adenocarcinoma.

Wang, Ning; Li, Yuanyuan; Zhou, Xue; Wang, Xue; Yang, Guoyue

Wang, Ning; Li, Yuanyuan; Zhou, Xue; Wang, Xue; Yang, Guoyue.

Afiliação

Wang N; The Third Central Hospital of Tianjin, Tianjin, 300170, China. Electronic address: wxxwjy@yeah.net.
Li Y; Department of Oncology, The Third Central Hospital of Tianjin, Tianjin, 300170, China.
Zhou X; Department of Nephrology, Tianjin Haihe Hospital, Tianjin, 300350, China.
Wang X; Department of Respiratory Medicine, The Third Central Hospital of Tianjin, Tianjin, 300170, China.
Yang G; The Third Central Hospital of Tianjin, Tianjin, 300170, China.

Comput Biol Med ; 153: 106448, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36586227

Assuntos

Adenocarcinoma de Pulmão; Neoplasias Pulmonares; Humanos; Adenocarcinoma de Pulmão/genética; Biomarcadores; Proliferação de Células; Neoplasias Pulmonares/diagnóstico; Neoplasias Pulmonares/genética; Prognóstico

Palavras-chave

ARHGEF6; Bioinformatics; Biomarker; Immuno-oncology; Lung adenocarcinoma; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Comput Biol Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google